"This Phase III randomized, multi-center, clinical trial compares standard therapy to prevent repeated stroke and the management of iron overload in pediatric patients (red cell transfusions and iron chelation) with an alternative therapy consisting of the medication, hydroxyurea, combined with phlebotomy, which is the removal of red blood cells."